Acten and Joint Replacement

The National Joint Registry (NJR Centre) reported that last year in the UK there were approximately 160,000 hip and knee replacements. This figure has been fairly constant for the past 5 years and has been managed within the National Health Service by altering the criteria for individuals to become eligible for the procedure.

Contributory factors for joint replacement

Arthritis Research UK (Arthritis Research UK) have stated that the main reason for joint replacement is Osteoarthritis, a degenerative condition particularly affecting the major weight-bearing joints and thought to affect over 8.75 million people in the UK alone. Articular cartilage is the structure which lines the ends of bones within a joint and will gradually begin to thin overtime before eventually resulting in bone on bone contact, joint degeneration and pain. This is a natural process but can be accelerated by joint trauma, particularly involving surgery, obesity, high loads placed through the joints on a regular basis.

Acten and articular cartilage

Acten contains a form of collagen which has been proven to stimulate the production of articular cartilage. This increase in cartilage depth results in reduced pain, increased range of movement within a joint and consequently improved overall function. Acten allows it’s users to enjoy more movement with less discomfort which will ultimately improve our quality of life.